Invicro is a leading provider of imaging services and analytics solutions that support the pharmaceutical and biotechnology industries in drug discovery and development. The company operates in the healthcare and life sciences market, offering a comprehensive suite of services that span from preclinical imaging to late-phase clinical trials. Invicro's core capabilities include preclinical imaging, early clinical imaging, imaging core lab services, pathology, radiochemistry, and image analysis software. By leveraging advanced imaging techniques and quantitative biomarkers, Invicro helps its clients gain critical insights into the efficacy and safety of new drugs. The company's business model revolves around providing these specialized services to top pharma and biotech companies, thereby generating revenue through service contracts and long-term partnerships. Invicro's expertise in managing large-scale research trials and processing vast amounts of imaging data positions it as a key player in the drug development process.

Keywords: imaging services, drug discovery, quantitative biomarkers, analytics solutions, preclinical imaging, clinical trials, radiochemistry, pathology, image analysis, pharmaceutical industry.